Damora Therapeutics Inc. (DMRA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Damora Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 9.05 M $234.28 M   3,686.65% 681.63%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2026 8.71 M $225.67 M   100.00% 656.57%
AVORO CAPITAL ADVISORS LLC 05/15/2026 3.78 M $97.98 M   100.00% 285.07%
VR ADVISER, LLC 05/15/2026 3.60 M $93.33 M   100.00% 271.55%
FCPM III SERVICES B.V. 05/15/2026 2.44 M $63.22 M   100.00% 183.94%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 2.40 M $62.14 M   100.00% 180.80%
JANUS HENDERSON GROUP PLC 05/18/2026 2.36 M $61.44 M   135,765.21% 178.04%
VIKING GLOBAL INVESTORS LP 05/15/2026 2.31 M $59.86 M   100.00% 174.15%
BELLEVUE GROUP AG 05/15/2026 2.30 M $59.52 M   100.00% 173.17%
05/19/2026 2.05 M $52.98 M   1,597.87% 154.14%
COMMODORE CAPITAL LP 05/15/2026 1.94 M $50.22 M   100.00% 146.11%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 1.53 M $39.50 M   100.00% 114.92%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.45 M $37.50 M   100.00% 109.12%
AH CAPITAL MANAGEMENT, L.L.C. 05/15/2026 1.24 M $32.02 M   100.00% 93.15%
PERCEPTIVE ADVISORS LLC 05/29/2026 1.22 M $31.68 M   100.00% 92.16%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.19 M $30.92 M   995.15% 89.95%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.06 M $27.40 M   100.00% 79.73%
SIREN, L.L.C. 05/14/2026 900.00 K $23.31 M   100.00% 67.82%
BRAIDWELL LP 05/15/2026 894.85 K $23.18 M   100.00% 67.43%
VESTAL POINT CAPITAL, LP 05/15/2026 600.00 K $15.54 M   100.00% 45.21%
BLACKSTONE INC. 05/15/2026 503.52 K $13.04 M   100.00% 37.94%
MILLENNIUM MANAGEMENT LLC 05/15/2026 471.65 K $12.22 M   100.00% 35.54%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 450.00 K $11.66 M   100.00% 33.91%
IKARIAN CAPITAL, LLC 05/15/2026 335.71 K $8.69 M   17.50% 25.30%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 282.44 K $7.32 M   100.00% 21.28%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 279.00 K $7.23 M   100.00% 21.02%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 278.00 K $7.20 M   100.00% 20.95%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 241.13 K $6.25 M   1,983.52% 18.17%
BLACKROCK, INC. 05/13/2026 222.44 K $5.76 M   2,857.94% 16.76%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 201.85 K $5.23 M   100.00% 15.21%
STATE STREET CORP 05/15/2026 183.92 K $4.76 M   100.00% 13.86%
MARSHALL WACE, LLP 05/15/2026 169.82 K $4.40 M   100.00% 12.80%
UBS GROUP AG 05/05/2026 160.42 K $4.15 M   2,410.80% 12.09%
05/15/2026 139.00 K $3.60 M   100.00% 10.47%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 110.44 K $2.86 M   15.29% 8.32%
06/04/2026 101.25 K $2.62 M   100.00% 7.63%
MORGAN STANLEY 05/15/2026 96.78 K $2.51 M   29.18% 7.29%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 96.66 K $2.50 M   100.00% 7.28%
GOLDMAN SACHS GROUP INC 05/15/2026 88.34 K $2.29 M   100.00% 6.66%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 76.34 K $1.98 M   100.00% 5.75%
HRT FINANCIAL LP 05/14/2026 72.11 K $1.87 M   100.00% 5.43%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 55.23 K $1.43 M   100.00% 4.16%
NORTHERN TRUST CORP 05/14/2026 38.88 K $1.01 M   100.00% 2.93%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 05/12/2026 24.46 K $633.41 K   100.00% 1.84%
SQUAREPOINT OPS LLC 05/15/2026 23.46 K $607.56 K   100.00% 1.77%
BARCLAYS PLC 05/15/2026 22.03 K $570.68 K   100.00% 1.66%
CATALYST FUNDS MANAGEMENT PTY LTD 05/11/2026 17.29 K $447.89 K   100.00% 1.30%
BANK OF AMERICA CORP /DE/ 05/18/2026 15.65 K $405.26 K   1,174.19% 1.18%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 12.50 K $323.75 K   100.00% 0.94%
JANE STREET GROUP, LLC 05/12/2026 11.42 K $295.78 K   100.00% 0.86%

Damora Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 61 institutional investors and hedge funds held shares of Damora Therapeutics Inc.. The most heavily invested institutionals were:

Cannon Global Investment Management, LLC: 0

Y-Intercept (Hong Kong) Ltd: 0

FMR LLC: 9.05 M

Fairmount Funds Management LLC: 8.71 M

Avoro Capital Advisors LLC: 3.78 M

VR Adviser, LLC: 3.6 M

163.26% of Damora Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 53.50 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.